Women in Pharma: Spain at the Vanguard
Spanish pharma is performing well-above other industries in terms of the percentage of women it employs in leadership positions. Spanish-native Belén Garijo, global CEO of Merck Healthcare since January 2015,…
Spanish pharma is performing well-above other industries in terms of the percentage of women it employs in leadership positions. Spanish-native Belén Garijo, global CEO of Merck Healthcare since January 2015,…
Cristobal Thompson of the AMIIF examines the steps forward that Mexican pharma has made in countering corruption, the areas in which urgent improvement is still needed, and outlines the three…
Tom Achoki of Mass Sciences explores the possibilities that better access to high-quality real-world data will create for accelerating novel drug discovery and ultimately improving patient outcomes. Proactive decision…
Click here to register and download PharmaBoardroom’s latest report: Healthcare & Life Sciences Review: China. From the world’s ninth largest pharma market in 2007 to its second-biggest merely 12…
After months of discussion, in December 2017 Egypt’s Parliament approved a new national health insurance law that aims to overcome some of the inherent problems in the current healthcare system…
A new report from specialist pharma and biotech consultancy Novasecta explores how the world’s top 100 pharma companies are shaping the future of healthcare. Through an examination of the various…
The Foundations for Evidence-Based Policy-Making Act, recently signed into law in the USA, stands to make government data more accessible; thereby allowing researchers, statisticians and others inside and outside of…
China’s unbridled growth has spurred a vast number of overseas Chinese to return home to seek new opportunities in their transformed homeland. Affectionately known as ‘sea turtles’ because the Chinese…
OPINION: Keith Wolsko and Danielle Moore of cannabis industry recruitment specialists Simply Kind Solutions highlight the seismic recent growth of the USA’s burgeoning cannabis industry and the kinds of profiles…
Eurasia Group’s Aditya Bhattacharji discusses the relatively modest scope of Malaysia’s recently-launched ‘MYSalam’ scheme; a healthcare programme which aims to provide coverage to the country’s bottom 40 percent of earners.…
GSK’s Richard Saynor outlines the ways in which an increased embrace of technologies which utilise artificial intelligence can help improve health literacy and therefore patient outcomes. In healthcare, AI…
Saul Kaye of iCAN and CannaTech outlines a compelling case for Israel to be considered one of the world’s leading hostpots for medical cannabis; drawing on its R&D history, specific…
See our Cookie Privacy Policy Here
